Literature DB >> 20674996

Acidic and basic fibroblast growth factors involved in cardiac angiogenesis following infarction.

Tieqiang Zhao1, Wenyuan Zhao, Yuanjian Chen, Robert A Ahokas, Yao Sun.   

Abstract

Acidic and basic fibroblast growth factors (FGF-1/FGF-2) promote angiogenesis in cancer. Angiogenesis is integral to cardiac repair following myocardial infarction (MI). The potential regulation of FGF-1/FGF-2 in cardiac angiogenesis postMI remains unexplored. Herein, we examined the temporal and spatial expression of FGF-1/FGF-2 and FGF receptors (FGFR) in the infarcted rat heart at days 1, 3, 7, and 14 postMI. FGF-1/-2 gene and protein expression, cells expressing FGF-1/-2 and FGFR expression were examined by quantitative in situ hybridization, RT-PCR; western blot, immunohistochemistry and quantitative in vitro autoradiography. Compared to the normal heart, we found that in the border zone and infarcted myocardium 1) FGF-1 gene expression was increased in the first week postMI and returned to control levels at week 2; FGF-1 protein levels were, however, largely reduced at day 1, then elevated at day 3 peaked at day 7 and declined at day 14; and cells expressing FGF-1 were primarily inflammatory cells; 2) FGF-2 gene expression was significantly elevated from day 1 to day 14; the increase in FGF-2 protein level was most evident at day 7 and cells expressing FGF-2 were primarily endothelial cells; 3) FGFR expression started to increase at day 3 and remained elevated thereafter; and 4) FGF-1/FGF-2 and FGFR expression remained unchanged in the noninfarcted myocardium. Thus, FGF-1/FGF-2 and FGFR expression are enhanced in the infarcted myocardium in the early stage after MI, which is spatially and temporally coincident with angiogenesis, suggesting that FGF-1/FGF-2 are involved in regulating cardiac angiogenesis and repair.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674996      PMCID: PMC3061206          DOI: 10.1016/j.ijcard.2010.07.024

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  36 in total

Review 1.  The future of therapeutic myocardial angiogenesis.

Authors:  Munir Boodhwani; Neel R Sodha; Roger J Laham; Frank W Sellke
Journal:  Shock       Date:  2006-10       Impact factor: 3.454

Review 2.  The role of fibroblast growth factors and their receptors in prostate cancer.

Authors:  B Kwabi-Addo; M Ozen; M Ittmann
Journal:  Endocr Relat Cancer       Date:  2004-12       Impact factor: 5.678

3.  Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.

Authors:  M Relf; S LeJeune; P A Scott; S Fox; K Smith; R Leek; A Moghaddam; R Whitehouse; R Bicknell; A L Harris
Journal:  Cancer Res       Date:  1997-03-01       Impact factor: 12.701

Review 4.  Antiangiogenesis for rheumatoid arthritis.

Authors:  Aldo M Roccaro; Francesca Russo; Teresa Cirulli; Guilia Di Pietro; Angelo Vacca; Franco Dammacco
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-02

5.  Expression of the multifunctional Y-box protein, YB-1, in myofibroblasts of the infarcted rat heart.

Authors:  German Kamalov; Balwantkumar R Varma; Li Lu; Yao Sun; Karl T Weber; Ramareddy V Guntaka
Journal:  Biochem Biophys Res Commun       Date:  2005-08-19       Impact factor: 3.575

6.  Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.

Authors:  Y Sun; J Q Zhang; J Zhang; F J Ramires
Journal:  J Mol Cell Cardiol       Date:  1998-08       Impact factor: 5.000

7.  Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma.

Authors:  Elisabetta Cenni; Francesca Perut; Donatella Granchi; Sofia Avnet; Ilaria Amato; Maria Luisa Brandi; Armando Giunti; Nicola Baldini
Journal:  Anticancer Res       Date:  2007 Jan-Feb       Impact factor: 2.480

8.  Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice.

Authors:  Machteld J van Amerongen; Martin C Harmsen; Nico van Rooijen; Arjen H Petersen; Marja J A van Luyn
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

9.  Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium.

Authors:  Ioannis Bougioukas; Vassilios Didilis; Petros Ypsilantis; Alexandra Giatromanolaki; Efthimios Sivridis; Theodoros Lialiaris; Dimitrios Mikroulis; Constantinos Simopoulos; Georgios Bougioukas
Journal:  Cardiovasc Pathol       Date:  2007 Mar-Apr       Impact factor: 2.185

Review 10.  Angiogenesis--a new target for future therapy.

Authors:  Nilesh M Pandya; Naranjan S Dhalla; Dev D Santani
Journal:  Vascul Pharmacol       Date:  2006-03-20       Impact factor: 5.773

View more
  17 in total

Review 1.  The epicardium as a hub for heart regeneration.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

2.  Myoblasts and embryonic stem cells differentially engraft in a mouse model of genetic dilated cardiomyopathy.

Authors:  Cyril Catelain; Stéphanie Riveron; Aurélie Papadopoulos; Nathalie Mougenot; Adeline Jacquet; Karine Vauchez; Erica Yada; Michel Pucéat; Marc Fiszman; Gillian Butler-Browne; Gisèle Bonne; Jean-Thomas Vilquin
Journal:  Mol Ther       Date:  2013-02-26       Impact factor: 11.454

Review 3.  Angiogenic growth factors in myocardial infarction: a critical appraisal.

Authors:  Hemalatha Thiagarajan; UmaMaheswari Thiyagamoorthy; Iswariya Shanmugham; Gunadharini Dharmalingam Nandagopal; Anbukkarasi Kaliyaperumal
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

4.  VEGF-C/VEGFR-3 pathway promotes myocyte hypertrophy and survival in the infarcted myocardium.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Weixin Meng; Chang Liu; Yuanjian Chen; Ivan C Gerling; Karl T Weber; Syamal K Bhattacharya; Rahul Kumar; Yao Sun
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

5.  Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Yuanjian Chen; Li Liu; Robert A Ahokas; Yao Sun
Journal:  Int J Cardiol       Date:  2012-07-19       Impact factor: 4.164

6.  Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.

Authors:  Yuanjian Chen; Wenyuan Zhao; Chang Liu; Weixin Meng; Tieqiang Zhao; Syamal K Bhattacharya; Yao Sun
Journal:  Am J Hypertens       Date:  2019-04-22       Impact factor: 2.689

7.  Platelet-derived growth factor blockade on cardiac remodeling following infarction.

Authors:  Chang Liu; Wenyuan Zhao; Weixin Meng; Tieqiang Zhao; Yuanjian Chen; Robert A Ahokas; Hongyu Liu; Yao Sun
Journal:  Mol Cell Biochem       Date:  2014-08-23       Impact factor: 3.396

8.  Platelet-derived growth factor involvement in myocardial remodeling following infarction.

Authors:  Wenyuan Zhao; Tieqiang Zhao; Valerie Huang; Yuanjian Chen; Robert A Ahokas; Yao Sun
Journal:  J Mol Cell Cardiol       Date:  2011-07-13       Impact factor: 5.000

9.  Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury.

Authors:  Stacey L House; Angela M Castro; Traian S Lupu; Carla Weinheimer; Craig Smith; Attila Kovacs; David M Ornitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-08       Impact factor: 4.733

10.  Analysis of stromal cell secretomes reveals a critical role for stromal cell-derived hepatocyte growth factor and fibronectin in angiogenesis.

Authors:  Andrew C Newman; Wayne Chou; Katrina M Welch-Reardon; Ashley H Fong; Stephanie A Popson; Duc Thien Phan; Daniel R Sandoval; Dananh P Nguyen; Paul D Gershon; Christopher C W Hughes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.